Introduction
Over the past three decades researchers have witnessed an enormous amount of activity in 9 the area of biosensors. The major processes involved in any biosensor system are analyte 10 recognition, signal transduction, and readout. Due to their specificity, speed, portability, 11 and low cost, biosensors offer exciting opportunities for numerous decentralized clinical 12 applications -point of care systems. 13 The ongoing trend in biomedicine is to go smaller. For almost a decade, the buzz word has 14 been nano, and the analytical micro devices are now appearing in the clinic. The progress 15 within microfluidic technologies has enabled miniaturization of biomedical systems and 16 biosensors. The down-scaling has several advantages: refined control of fluidics, low sample 17 consumption, applicability to point of care, and low cost. 18 Point of care is an emerging field within medical diagnostics and disease monitoring, and 19 eventually disease control. Employing specially designed micro systems, a patient can be 20 monitored continuously at bed side, and save precious time on commuting between home, 21 doctor and hospital. The technological advancements in the biosensor technology within 22 recent years have accelerated the R&D in point of care devices. 23 Cost benefit is always an important factor in development of novel medical devices. To 24 reduce the expenses of biosensors, the use and cleanroom processing of noble metals should 25 be kept at a minimum. Therefore, we predict a shift in the usage of gold and platinum to 26 degradable polymer materials. 27 This chapter will look further into the advantages and applications of all-polymer 28 microfluidic devices for biomedical diagnostics and compare with traditional systems. In 29 many biosensor applications, only one analyte is of interest, and preferentially it should be 30 isolated from an inhomogeneous patient sample. Section 2 provides the reader with an 31 overview of the different novel microfluidic separation techniques in polymeric devices. 32 Conductive polymers are the focus of section 3. They have many excellent properties and in 33 fact, they can compete with gold in many applications. The focus of section 4 is sensitivity 34
and specificity of biosensors. High sensitivity and specificity is crucial and can be achieved 35 by functionalization with different molecules. The section will primarily center around the 36 use of aptamers which is favourable above antibodies. Different detection methods are 37 applied in biosensors, some of the promising techniques will be summarized in section 5. 38 Finally, section 6 gives an overview of the current status in biosensor development while 39 focusing on ongoing research. 40
Novel microfluidic separation techniques for sample preparation 1
The progress in microfabrication and lab-on-a-chip technologies is a major field for 2 development of new approaches to bioanalytics and cell biology. Microfluidics has proven 3 successful for cell and particle handling, and the interest in microdevices for separation of 4 particles or cells has increased significantly (Giddings (1993) ; Nolan & Sklar (1998) ; Toner & 5 Irimia (2005)). 6 Biological samples comprise a heterogeneous population of cells or particles, which is 7 inconvenient for many biomedical applications, where the objective of study is often just 8 one species. For example, the isolation of CD4+ T-lymphocytes from whole blood is 9 essential to diagnose human immunodeficiency virus (HIV) (Kuntaegowdanahalli et al. 10 (2009)), the isolation of leukocytes is important in drug screening assays, and the isolation of 11 specific micro particles from blood plasma is critical for our understanding of inflammatory 12
diseases. Thus, separation of cells or particles has a wide range of applications within 13 different areas of medicine such as diagnostics, therapeutics, drug discovery, and 14 personalized medicine (Gossett et al. (2010) ). 15 Flow cytometry has remained the preferred method for cell sorting by many biologists 16 because the technique is well established and has both high sensitivity and high throughput. 17 Recently, fluorescence based sorting of cells and particles has also been implemented in 18 microfluidic devices. 19 The microfluidic separation techniques are broadly classified as being either passive or 20 active, depending on the operating principles (Table 1) . Active separation of particles 21 requires an external force (i.e. electrical power, mechanical pressure or magnetic force), 22 whereas passive separation techniques rely on channel geometry and inherent 23 hydrodynamic forces for functionality (i.e. pillars, pressure field gradient or hydrodynamic 24 force). The following section will introduce a couple of novel separation principles with 25 application in biomedical sensors. For further reading on continuous separation of particles, 26 see review papers by Lenshof Acoustophoresis is the separation of particles using high intensity sound waves. In a 33 microfluidic system, particles with an induced acoustic standing wave will experience a 34 force towards a node or anti node dependent on their physical properties (Lenshof & Laurell 35 (2010) ). If two particles suspended in a fluid have opposite acoustic contrast, a separation 1 will occur gathering one at node and the other at anti-node. Generally, rigid particles will 2 have negative phase and move toward the node, whereas air bubbles and lipid vesicles 3 gather at the anti-node (Lenshof & Laurell (2010) ). After separation, the properties of the 4 laminar flow in the microfluidic channel ensure that particles remain at their position in the 5 channel, hence they can be collected separately with a flow splitter. 6 Both particles with opposite and similar acoustic contrast can be separated using this 7
technique. The size of particles will influence the time scale. Large particles experience a 8
higher force than small than the smaller ones, and thus gather at the node faster than the 9 small particles. Peterson et al. (2007) described a microfluidic system with three inlets ( Fig.  10 1), where a sample composed of different sized particles was introduced at the sides of a 11 microfluidic channel with a sheath fluid in the middle to keep particles in close proximity to 12 channel walls. The system is designed such that an ultrasonic transducer induces a force on 13 the particles, which forces them towards the middle of the channel. Since the larger particles 14 experience a higher force than small particles, they large particles immediately gather at the 15 center of the channel. Particles are thus allocated proportional to their size. Making use of a 16
flow splitter, particles are separated according to their size. Applying this technique, 17 Peterson 
Ion depletion 27
Ion depletion is a microfluidic technique for separation and concentration of proteins. As the 28 name indicates, the method is based on ion transfer in a nanofluidic channel (approximately 29 50 nm in depth). Counter-ions will migrate from the Debye layer through the nanochannel 30
to a higher extent than co-ions, so that a net transfer of counter-ions is transferred from the 31 anodic side to the cathodic side. Thus, the concentration of counter-ions decreases on the 32 anodic side and an increase is achieved on the cathodic side. If a protein in solution is part of 33 the co-ion population, this protein will be trapped in a plug on either side of the ion 34 depletion region, and is hence separated from the bulk solution. The principle of ion 35 depletion is illustrated on Obstacles arranged in microfluidic channels are commonly applied for preventing particles 9 from entering certain areas or used to manipulate the flow of fluid in a microchannel. 10 Deterministic lateral displacement is a method for size separation of particles or cells, 11
accomplished by placing posts asymmetrically in a microchannel ( Fig. 4 ) and thus forcing 12 particles of different sizes to follow different flow paths. 13
Spiral microchannels 14
Separation of particles in a spiral microchannel was described by Kuntaegowdanahalli and 15 colleagues (2009) (see Fig. 5 ). 16 It is a passive separation technique based on the centrifugal force. 6 Modern biosensors for medical diagnostics must be specific, quick, and producible at 7 reasonable cost. A major cost factor is the electrode material -often a noble metal -8
Conductive polymers for sensing
demanding extensive production steps in cleanroom facilities. To cut down on these 9
expenses there is a trend to utilize conductive polymers for sensing. This section will give an 10 introduction to advantages of conductive polymers compared to noble metals, and guide 11 through the considerations associated with selecting an appropriate polymer material for 12 biosensor applications. 13
Polymers or metals? 14
The application of polymers as supporting materials in microfluidic systems is well 15 established, however the electronic sensing units in most chips are fabricated from metallic 16 conductors such as platinum or gold. 17
Biocompatibility, high sensitivity and specificity are a demand in modern medical 18 biosensors. Biocompatibility is required because some biological applications involve living 19 cells, bacteria or virus. High specificity and sensitivity is essential for detecting highly 20 diluted analytes in biological samples, because the samples contain a cocktail of similar 21 components, which can influence a measurement. All of these requirements can be fulfilled 22 by the metal electrode materials such as solid platinum or gold (Prodromidis & Karayannis,  23 2002). Though, a major disadvantage of the noble metals is the high cost, which is 24 continuously increasing. 25
Conjugated polymers are an alternative to the traditional electrode materials. The electronic 26 structure of these compounds gives them properties similar to inorganic semiconductors. In 27 1977, Shirakawa et al. discovered that doping polyacetylene with halogens increased the 28 conductivity by up to four orders of magnitude. The following research on this topic by 29 Shirakawa, MacDiarmid and Heeger was awarded with the Nobel prize in chemistry in 30 2000. 31 Over the years, electronically conductive polymers have been proposed for many 32 applications (Jagur- 
PEDOT 3
Improved properties compared to PPy were found for poly(3,4-ethylenedioxythiophene) or 4
PEDOT. It is either chemically or electrically polymerized from the commercially available 5 monomer 3,4-ethylenedioxythiophene. As can be seen in figure 6(b) , it has some structural 6 similarities with PPy. PEDOT has exceptional high conductivity (up to 600 S·cm−1 ), high 7 environmental stability and is biocompatible and transparent for visible light. The most 8 common dopants used for PEDOT are poly(styrene sulfonate) (PSS) and tosylate (Rozlosnik 9 (2009)). in a number of biosensor microdevices. 17 An interesting study was presented by Kumar et al. (2006) . A biosensor was developed to 18 determine the concentration of the important mammalian neurotransmitter, dopamine via 19 an electrochemical process. Since the concentration of ascorbic acid is around a thousand 20 times higher than dopamine in a biological sample, and the two analytes have similar 21 electrochemical potentials, the challenge was to measure the concentration of dopamine in 22
presence of ascorbic acid. Kumar et al. (2006) employed glassy carbon electrodes coated  23 with PEDOT, and their findings demonstrated significant peak separation and improved 24
anti-fouling properties compared to the more common electrode material glassy carbon, 25
making PEDOT a good candidate for further applications in this field. 26 Glucose detection for blood sugar monitoring of diabetes patients is a huge and growing 27 market for disposable biosensors. The established commercial systems make use of metal 28 electrodes (typically Pt) coated with a gel containing the enzyme glucose oxidase, and the 1 effectively measured agent is thus the oxidation product, hydrogen peroxide (H2O2 ). 2 In contrast to the direct oxidation of dopamine on the electrodes in the example above, this 3
indirect detection of glucose is more complicated. Considering the current market price of 4 platinum of about 41 €/g (http://platinumprice.org), replacing the electrode material with a 5 low cost polymer such as PEDOT seems sensible. Park et al. (2008) imprisoned glucose 6 oxidase in hollow PEDOT micro-tubules on an indium-tin-oxide (ITO) glass surface (figure 7 7) . In this configuration, the enzymes are surrounded by the electrode, and therefore their 8 activity is not constrained by immobilization on a surface or incorporation into a polymer. 9
Although the performance of this biosensor cannot meet the requirements of a classic 10 system, it can be refined by increasing the enzyme density or improving the conductivity. 11
Many biosensors for pathogen detection are based on antibodies as probes, and deliver an 12
indirect signal. These immunosensors require a fluorescently tagged second antibody, 13 which reacts with occupied immobilized antibodies in a so-called sandwich assay. antigen was captured by immobilized antibodies on the conductive polymer. For signal 20 enhancement, a secondary antibody with a covalently tethered gold nanoparticle was used. 21 The system provided a detection limit as low as 1 pg·mL−1 and is thus sensitive enough for 22
reliable PSA-ACT analysis. 23
PEDOT derivatives 24
A field effect transistor (FET) based biosensor was demonstrated by Xie et al. (2009). The  25 working principle is fundamentally different, considering it uses conductive polymer 26 nanowires, which were electropolymerized between two gold electrodes. For minimizing 27 the distance between polymer and binding event it was necessary to couple the probe 28
(an aptamer, see also section 4.3) directly to the electrode material. Normal PEDOT offers 29 no possibility for covalent bonding of other molecules, so a derivative bearing a carboxylic 30 acid group was used. With this functional group the oligonucleotide for thrombin 31 detection was attached with a simple 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide/N- 32 hydroxysuccinimide procedure (see section 3.3, (EDC/NHS)). Thrombin binds specifically 33 to aptamers and becomes immobilized on the surface. The positively charged protein 34 influences the transistor, so that the current flow changes. This type of biosensor has a broad 35 dynamic range covering the physiologically interesting thrombin concentration range from 36 a few nanomoles to several hundred nanomoles. 37 Other PEDOT derivatives have also been investigated (commonly known as hydroxymethyl-EDOT or EDOT-OH) (8(a)), and it can be used as a 43 basis for further modifications. 44
Coupling methods 1
There are different techniques for immobilization of biomolecules (e.g. DNA) on an 2 electrode surface. The most popular methods are formation of a biotin-streptavidin complex, 3 formation of different covalent bonds like esters or amides, or click chemistry. 2008). 10
Biotin-streptavidin complex 11
Streptavidin is a protein consisting of four identical subunits, each of which has an 12 extremely high affinity for biotin. A biotinylated surface can be coated with streptavidin so 13 it offers reactive sites for fixation of likewise biotin tagged (bio)molecules. The biotin-14 streptavidin interaction is one of the strongest non-covalent bonds in nature and it is very 15 specific. Moreover, the system is easy to handle and very biocompatible. 16 Despite the many advantages of streptavidin, a major drawback is the instability at low or 17
high pH values, and high temperature. For some detection methods the rather thick protein 18 layer between electrode and probe can substantially decrease the sensitivity of the sensor. For hydroxyl functionalized polymers and target molecules, a technique from DNA 27 synthesis can be employed. The alcohol groups are activated with phosphoramidites to form 28 a phosphoester, which then reacts with another hydroxyl moiety and links the target 29 molecules covalently to the surface (Pirrung, 2002) . 30
Click chemistry 31
A very elegant approach for probe immobilisation is the usage of so called "click-32 chemistry". In the Cu-catalysed Huisgen-type 1,3-cycloaddition suggested by Daugaard et 33 al. (2008) an azide reacts in high yield with an alkyne to form a five-membered heterocycle. 1
This bond is very stable and also the precursors have advantages such as stability toward 2 hydrolysis and dimerization or ease of introduction (Kolb et al. 2001 ). 3 However, the azide functionalization of PEDOT downgraded its conductive properties 4 significantly and remaining Cu catalyst could influence biological systems. 5 4. Electrode functionalization 6 Functionalization of electrodes is essential for achieving high sensitivity and specificity of 7 electrochemical biosensors. This section provides an overview of the current trend in 8 electrochemical sensors for medical diagnostics. 9
Recognition of pathogens 10
Point of care diagnostic devices present a viable option for rapid and sensitive detection and 11 analysis of pathogens. Biosensors can play an important role in the early diagnosis of acute 12 viral disease and confine the spread of virulent disease outbreaks. Biosensors can also play 13 an important role in early detection and diagnosis of cancer and autoimmune disorders 14
based on specific biochemical markers. 15 As discussed in section 2, separation and isolation of large quantities of a specific analyte 16 would be preferable for many medical applications. 17 Patient samples comprise of a heterogeneous population of particles and cells, hence 18 challenging the isolation of a single species in a high background concentration. For this 19 reason, biosensors must be very specific and sensitive, allowing precise detection of very 20
small quantities. 21
Antibodies 22
Many techniques for preparing functional biological surfaces for studies of cells, viruses or 23 disease markers have been described in the literature. Refer to 3.3 for an overview of 24 different coupling methods. 25
Immunoglobulins (IgG) are large Y-shaped proteins produced by the immune system, and 26 are most abundant in blood plasma. Two identical antigen binding sites are formed from 27 several loops of the polypeptide chain. These loops allow many chemical groups to close in 28 on a ligand and link to it with many weak (non-covalent) reversible bonds. An antibody-29 antigen bond is highly specific because of the molecular structure of the protein. 30 Antibodies are the most common recognition molecule in biosensors. It is a naturally 31 occuring protein and can only be produced in a host against immunogenic substances, 32
giving rise to batch variation and a limited target range. For research purposes, monoclonal 33 or polyclonal antibodies can be applied as recognition molecule. Typically, monoclonal 34 antibodies will ensure a higher specificity than polyclonal antibodies. 35 In medical sensor applications, functional orientation of the antibodies on the surface is 36 crucial to ensure high sensitivity and specificity. It can be achieved by immobilizing the 37 proteins on a supporting layer of protein A. 38
Aptamers 39
For many years, antibodies have been applied for surface functionalization in biosensors, 40 ensuring specificity and sensitivity of sensors. Artificial nucleic acid ligands -known as 41 aptamers -can cover the same field of application as antibodies. In the recent years, the use 42 of aptamers has increased (Han et al. (2010) ; Syed & Pervaiz (2010)), and they are in many 1 ways superior to antibodies, as it will be disscused in this section. 2
The properties of aptamers 3
Aptamers are oligonucleotides with a typical length of forty to eighty basepairs, and were 4 discovered in the 1980's as naturally occurring regulation elements in prokaryotic cells, and 5 they showed high affinity for viral and cellular proteins. 6 In 1990, Tuerk & Gold developed a convenient process for in vitro aptamer production, the 7 so-called systematic evolution of ligands by exponential enrichment (SELEX, see in section 8 4.3.2). 9
Aptamers are in many regards better than antibodies as summarized in table 2. The affinity 10
for the target molecules of aptamers is similar to antibodies, and in some cases even higher 11 compared to antibodies. The specificity is also higher for aptamers, as they can distinguish 12
between targets of the same family, like it was shown for the molecules caffeine and 13
theophylline (Zimmermann et al., 2000) . Selection and production of the nucleic acid ligands 14
can be done in vitro, and once the correct sequence has been determined, the 15 oligonucleotide can be synthesized in an automated chemical procedure. The range for 16 possible target molecules is very wide and -in comparison with the mentioned biomolecules 17
-comprises all kinds of smaller ions, organic compounds and even whole cells. Contrary to 18 antibodies, aptamers can be selected against toxic compounds. 19
Due to the chemical synthesis, there is no significant batch variation and it allows for easy 20 chemical modification, like attachment of certain end groups for surface immobilization. 21 Reversible thermal denaturation makes aptamers potentially recyclable and their very high 22 stability promises long self life (Lee et al., 2008) . 23
The SELEX process 24
Aptamer production is accomplished in the SELEX (Systematic Evolution of Ligands by 25 Exponential Enrichment) process (see figure 9 ). A pool of single stranded oligonucleotides 26 with a random section of about 25 to 70 basepairs (the library) is incubated with the target 27 molecule. Some nucleic acid strands will interact with the target molecule and form strong 28 non-covalent bonds. Target-DNA-complexes are partitioned from unbound DNA. After 29 dissolution of the complex, the selected oligonucleotides are amplified in a standard PCR 30 process. DNA strands are separated and the whole procedure is repeated for up to 20 times 31 in order to select the best fitting sequences. 32 If RNA is used, a transcription step must be inserted before and after PCR. In order to 33 increase specificity for the target molecule and exclude unspecific binding, counter selection 34 steps can be employed. In those selection rounds no target is used and DNA strands with 35 affinity to the support and container material are removed from the pool 36
Biosensor applications 37
In order to eliminate systematic problems with sandwich assays, the development of label 38 free biosensors is an interesting topic. Xiao et al. (2005) modified a thrombin specific 39 aptamer with a thiol group for immobilization on a gold surface. The strand was partially 40
hybridised with a not fully complementary strand bearing a methylene blue (MB) tag. 41 In presence of thrombin, the strands separated and the MB redox tag was approximated to 42 the Au surface ( figure 10(a) ). 43 1 Fig. 9 . The SELEX process for use with a DNA library (Nimjee et al. (2006) ). Binding the charged protein induced an electrostatic gate potential and changed the source-12 drain current. The field effect transistor (FET) biosensor was able to detect thrombin in a 13 concentration range of 10 -100 nM. 14 15 Aptamers Antibodies Affinity
Low nM -pM Low nM -pM Specificity High High Production
In vitro chemical process In vivo biological process 
Electrical detection methods

10
The electrical detection has traditionally received the major share of the attention in 11 biosensor development. Such devices produce a simple, inexpensive and yet accurate and 12 sensitive platform for patient diagnosis. The name electrochemical biosensor is applied to a 13 molecular sensing device which intimately couples a biological recognition element to an 14 electrode transducer. The purpose of the transducer is to convert the biological recognition 15 event into a useful electrical signal. 16 Electrochemical systems are extremely sensitive to the processes that take place on the 17 surfaces of the electrodes, and in this sense the electrodes are direct transducers in 18 biomedical applications. Several types of electrochemical methods are used in biosensors; 19 the two most common ones are the amperometry and impedance spectroscopy (EIS) (Lazcka 
Amperometry 1
Amperometry is a method of electrochemical analysis in which the signal of interest is a 2 current that is linearly dependent upon the concentration of the analyte. As certain chemical 3 species are oxidized or reduced (redox reactions) at the electrodes, electrons are transferred 4 from the analyte to the working electrode or to the analyte from the electrode. The direction 5 of flow of electrons depends upon the properties of the analyte and can be controlled by the 6 electric potential applied to the working electrode. 7
Amperometric biosensors operate by applying a constant potential and monitoring the 8 current associated with the reduction or oxidation of an electroactive species involved in the 9 recognition process. The amperometric biosensor is attractive because of its high sensitivity 10 and wide linear range. 11
Conductivity and impedance spectroscopy 12
Electrochemical impedance spectroscopy (EIS) combines analyses of both the resistive and 13 capacitive properties of materials, based on the perturbation of the system by a small-14
amplitude sinusoidal AC signal. The impedance of the system can be scanned over a wide 15 range of AC signal frequencies.
The amplitude of the current, potential signals, and the 16 resulting phase difference between voltage and current dictates the system impedance 17
Therefore, the impedance signal is dependent on the nature of the system under study. 18 Equivalent circuit models fitted to the impedance curves are useful tools for characterizing 19 the system. Although this methodology is widely accepted because of ease of use, extreme 20 care must be taken to ensure that the equivalent circuit obtained makes physical sense. An 21 advantage of EIS compared to amperometry is that redox labels are no longer necessary, 22 which simplifies the sensor preparation. 23
Organic field effect transistors 24
Organic field effect transistors (Organic FETs) have a potential being the active matrix for 25 many electronic devices, including biosensors for biological material. An organic field-effect 26 transistor consists of a source and drain electrode, an organic semiconductor (which is in 27 this case a conductive polymer), a gate dielectric, and a gate electrode. A number of different 28 studies have demonstrated conductance-based sensors employing a molecular receptor 29 layer immobilized on the surface of a semiconductor device. The receptor molecules provide 30 the means to achieve highly selective sensing because they can be engineered to have much 31 higher binding affinities with the desired target molecules than the other species in the 32 analyte solution (see section 4). Although the organic FET is a promising candidate for 33 biosensor applications, optimization of the device structure and operating conditions is still 34 required. 35
Outlook
36
In recent years, fascinating developments of a wide range of commercial applications have 37 occurred. Elegant research on new sensing concepts has opened the door to a wide variety 38 of microsystem based biosensors for clinical applications. Such devices are extremely useful 39 for delivering diagnostic information in a fast, simple, and low cost fashion, and are thus 40
uniquely qualified for meeting the demands of point of care systems, e.g. for cancer 41
screening. The high sensitivity of the modern biosensors should facilitate early detection 42 and treatment of diseases, and lead to increased patient survival rates. 43
In the future, one of the main challenges is to bring the new biosensor techniques to bed side 1 for use by non-laboratory personnel without compromising accuracy and reliability. The 2 internal calibration and reference is also a major requirement, and provoke researchers to 3 reshape the existing methods. From a clinical point of view, the in vivo biosensors that are 4 biocompatible and can remain in the body for weeks or months will also be a demand. 5
Special attention should be given to non-specific adsorption issues that commonly control 6 the detection limits of electrochemical bioaffinity assays. The stability of biosensors remains 7 an important issue in the fabrication and use of these devices for many application areas. 8 By measuring abnormalities within few minutes, disposable cartridges containing electrode 9 strips and simple sample processing could offer early and fast screening of diseases in a 10 point of care setting. 11
It has become apparent that the field of polymer biosensors has reached a new level of 12 maturity. In the near future it is highly likely that pathogen detection will undoubtedly 13 benefit from the integration of biosensors into all-polymer microdevices, and thus in some 14 regards revolutionize the medical diagnostics. 15 naphthalenesulfonic acid)) (pedot-pans) film modified glassy carbon electrode for 32 selective detection of dopamine in the presence of ascorbic acid and uric acid., 33
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